You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 3, January 19, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Psychoactive Drug Use and AIDS-Reply

Richard A. Kaslow, MD, MPH; William C. Blackwelder, PhD; David G. Ostrow, MD, PhD; Diane Yerg, MSPH; John Palenicek, PA-C; Anne H. Coulson; Ronald O. Valdiserri, MD, MPH
for the Multicenter AIDS Cohort Study From the National Institute of Allergy and Infec

JAMA. 1990;263(3):373.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Our study addressed the hypothesis that psychoactive substances, including alcohol, as they were used by homosexual men before and just after their enrollment in the Multi-center AIDS Cohort Study (MACS) in 1984 through 1985, did not enhance HIV-induced immunodeficiency. We offer the following response to comments on our findings.

First, both Drs Drexler and Brown and Dr Badgley emphasize the absence of data on the role of these substances in promoting seroconversion. We intentionally excluded the analysis of the effects of these psychoactive substances on initiation of infection. Early reports from the MACS1,2 and other reports have recognized potentially important relationships between use of these substances and the prevalence of HIV infection. A more complete analysis of MACS data on these relationships is in preparation. Assessment of such influences on new acquisition of HIV infection or antibody will be more difficult because of the relatively small numbers . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.